Cynata Therapeutics Statistics

Total Valuation

FRA:51S has a market cap or net worth of EUR 52.23 million. The enterprise value is 49.20 million.

Market Cap	52.23M
Enterprise Value	49.20M

Important Dates

The last earnings date was Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	241.75M
Shares Outstanding	n/a
Shares Change (YoY)	+14.10%
Shares Change (QoQ)	+22.37%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	187.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	49.63
PB Ratio	15.64
P/TBV Ratio	15.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-9.39
EV / Sales	43.49
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.40

Current Ratio	4.40
Quick Ratio	4.24
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -142.29% and return on invested capital (ROIC) is -91.02%.

Return on Equity (ROE)	-142.29%
Return on Assets (ROA)	-77.08%
Return on Invested Capital (ROIC)	-91.02%
Return on Capital Employed (ROCE)	-160.67%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	526,191
Profits Per Employee	-2.62M
Employee Count	2
Asset Turnover	0.24
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +32.64% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+32.64%
50-Day Moving Average	0.18
200-Day Moving Average	0.12
Relative Strength Index (RSI)	51.79
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:51S had revenue of EUR 1.05 million and -5.24 million in losses. Loss per share was -0.03.

Revenue	1.05M
Gross Profit	1.05M
Operating Income	-5.37M
Pretax Income	-5.24M
Net Income	-5.24M
EBITDA	-5.21M
EBIT	-5.37M
Loss Per Share	-0.03

Full Income Statement

Balance Sheet

The company has 2.82 million in cash and n/a in debt, with a net cash position of 2.82 million.

Cash & Cash Equivalents	2.82M
Total Debt	n/a
Net Cash	2.82M
Net Cash Per Share	n/a
Equity (Book Value)	3.34M
Book Value Per Share	0.01
Working Capital	2.31M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-4.87M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-509.82%
Pretax Margin	-498.14%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:51S does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.10%
Shareholder Yield	-14.10%
Earnings Yield	-10.04%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:51S has an Altman Z-Score of 0.28 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.28
Piotroski F-Score	2